Huda Y. Zoghbi - 13 Sep 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Huda Y. Zoghbi
Issuer symbol
REGN
Transactions as of
13 Sep 2021
Net transactions value
-$258,082
Form type
4
Filing time
15 Sep 2021, 16:03:12 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $784 +2 +0.22% $391.92 893 13 Sep 2021 Direct F1
transaction REGN Common Stock Sale $1,302 -2 -0.22% $651.10 891 13 Sep 2021 Direct F1
transaction REGN Common Stock Options Exercise $391,136 +998 +112% $391.92 1,889 14 Sep 2021 Direct F1
transaction REGN Common Stock Sale $648,700 -998 -53% $650.00 891 14 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2 -0.04% $0.000000 5,115 13 Sep 2021 Common Stock 2 $391.92 Direct F1, F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -998 -20% $0.000000 4,117 14 Sep 2021 Common Stock 998 $391.92 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.